Dave has worked with the partners of Solas BioVentures Fund since 2004 and was a founding member of the fund in 2014. He currently focuses on investments in the medical device and therapeutics area at all stages of maturation. Board certified in Maternal-Fetal Medicine, Obstetrics and Gynecology, and Hypertension, and having special expertise in Critical Care, Dave is a long-time physician, educator, administrator, innovator, and biotech/med-tech investor with nearly 20 years of experience in angel and venture investing. Dave currently serves as Professor, Vice Chairman of the Department of Obstetrics and Gynecology at the University of Tennessee College of Medicine. He has extensive Board and C-Suite experience.
DAVID ADAIR, MD, MBA
Co-Founder & Managing Director
MARK HACKETT, JD
Co-Founder & Partner
Mark is an attorney who has spent nearly 20 years practicing extensively in the life sciences and corporate law areas, including serving over 10 years as General Counsel to a biopharma and medtech company specializing in pregnancy health. Mark has handled a wide range of life science matters, including company financing, investor representation, M&A, strategic alliances, technology licensing, regulatory, IP strategy, and clinical, manufacturing and distribution contracting. Mark earned his B.A. from Tulane University and his J.D. from Vanderbilt University School of Law. Formerly a partner at a large, national law firm, Mark co-founded Evans Harrison Hackett PLLC in 2007, where he serves as managing partner. After managing several successful angel group investments, Mark and Dave teamed up with Casey to form Solas BioVentures Fund I in 2014.
Casey focuses on evaluating potential investments, financial analysis, due diligence and portfolio management. He also leads the Fund’s operational and administrative functions. He began his career as an analyst at Wellington Management Company, LLC. He joined Resolute Capital Partners’ predecessor at its inception in 2005, became a partner in 2007, and has been actively involved in each of its funds. Casey earned a Bachelor of Science in Business Administration degree from East Tennessee State University, an MBA from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill. Casey also earned the Chartered Financial Analyst designation in 2003.
CASEY HAMMONTREE, MBA, MBEE
Co-Founder & Partner
MICHAEL HOEY, PHD, MBA
Michael is a serial entrepreneur, founding eight medical products companies, one agricultural company, and one musical products company. Prior to that he taught and performed research at the University of Minnesota Medical School, the College of Engineering Sciences, and the Carlson School of Management. Professor Hoey also taught in the School of Biological Sciences at Hamline University in St. Paul, Minnesota. Michael was also Executive Chairman of a financial institution that he directed from $150M to more than $2.5B. Michael is a prolific inventor with over 200 patents granted and/or applied for. Collectively, the start-up medical companies he has been involved in raised $400 million of capital. Four of those companies combined have harvested greater than $1.5B and two more are commercializing product. He also harvested the musical company, and the agricultural company is in commercialization.